Tissue-of-origin determines immune cell heterogeneity and response to therapy via unique tumor cell-intrinsic factors

被引：0

作者：

Xie, Jane

Baslan, Timour

Stanger, Ben

机构：

来源：

CANCER IMMUNOLOGY RESEARCH | 2024年 / 12卷 / 10期

关键词：

D O I：

10.1158/2326-6074.TUMIMM24-A046

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

A046

引用

页数：2

共 50 条

[21] Pemetrexed Enhances Anti-Tumor Efficacy of PD-L1 blockade by Promoting Intra-Tumor Immune Response via Tumor and T Cell-Intrinsic Mechanisms
Schaer, D.
Geeganage, S.
Amaladas, N.
Lu, Z. H.
Rasmussen, E.
Sonyi, A.
Chin, D.
Capen, A.
Li, Y.
Meyer, C.
Jones, B.
Huang, X.
Luo, S.
Carpenito, C.
Roth, K.
Nikolayev, A.
Tan, B.
Brahmachary, M.
Chodavarapu, K.
Dorsey, F.
Manro, J.
Doman, T.
Donoho, G.
Hall, G.
Kalos, M.
Novosiadly, R.
JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S527 - S527
[22] Tumor Cell-Intrinsic BTLA Receptor Inhibits the Proliferation of Tumor Cells via ERK1/2
Cheng, Tian-You
Liu, Ya-Juan
Yan, Hong
Xi, Yi-Bo
Duan, Li-Qiang
Wang, Yang
Zhang, Tian-Tian
Gu, Yin-Min
Wang, Xiao-Dong
Wu, Chang-Xin
Gao, Shan
CELLS, 2022, 11 (24)
[23] Cell-intrinsic PD-L1 directs tumor initiating cell fate and rapamycin and interferon-γ response
Gupta, Harshita B.
Clark, Curtis A.
Yuan, Bin
Sareddy, Gangadhara
Pandeswara, Srilakshmi
Padron, Alvaro S.
Hurez, Vincent
Garcia, Jose-Conejo
Vadlamudi, Ratna
Li, Rong
Curiel, Tyler J.
CANCER RESEARCH, 2017, 77
[24] Tumor cell intrinsic factors in colorectal cancer immune evasion.
Wangmo, Dechen
Zhao, Xianda
Yuan, Angelo
Gates, Travis
Subramanian, Subree
CANCER RESEARCH, 2022, 82 (12)
[25] Sustained, cell-intrinsic versus intermittent, cell-extrinsic checkpoint blockade in solid tumor CAR T-cell therapy
Linot, Camille
Saini, Jasmeen
Adusumilli, Prasad S.
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (05)
[26] Multifaceted roles of PD-1 in tumorigenesis: From immune checkpoint to tumor cell-intrinsic function
Chen, Huiqing
Wei, Jiayu
Zhu, Zhen
Hou, Yongzhong
MOLECULAR CARCINOGENESIS, 2024, 63 (08) : 1436 - 1448
[27] Tumor Cell-intrinsic Activation of the Immune Receptor RIG-I in Combination with Immune Checkpoint Blockade improves anti-Tumor T-Cell Responses
Thier, B.
Such, L.
Sucker, A.
Coch, C.
Hartmann, G.
Schadendorf, D.
Griewank, K.
Trilling, M.
Zhao, F.
Paschen, A.
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2020, 18 : 10 - 10
[28] Investigation of tumor-cell-intrinsic factors regulating immune infiltration and response to immunotherapy in pancreatic cancer
Li, Jinyang
Byrne, Katelyn T.
Markosyan, Nune
Yamazoe, Taiji
Yan, Fangxue
Chen, Zeyu
Sun, Yu H.
Lin, Jeffrey
Sela, Yogev
Norgard, Robert J.
Yuan, Salina
Merrell, Allyson J.
Tobias, John W.
Vonderheide, Robert H.
Stanger, Ben Z.
CANCER RESEARCH, 2019, 79 (24)
[29] Tumor cell heterogeneity drives spatial organization of the intratumoral immune response
Tanaka, Miho
Lum, Lotus
Hu, Kenneth H.
Chaudhary, Piyush
Hughes, Savannah
Ledezma-Soto, Cecilia
Samad, Bushra
Superville, Daphne
Ng, Kenneth
Chumber, Arun
Benson, Ciara
Adams, Zoe N.
Kersten, Kelly
Aguilar, Oscar A.
Fong, Lawrence
Combes, Alexis J.
Krummel, Matthew F.
Reeves, Melissa Q.
JOURNAL OF EXPERIMENTAL MEDICINE, 2025, 222 (06):
[30] Tumor cell-intrinsic epigenetic dysregulation shapes cancer-associated fibroblasts heterogeneity to metabolically support pancreatic cancer
Niu, Ningning
Shen, Xuqing
Wang, Zheng
Chen, Yueyue
Weng, Yawen
Yu, Feier
Tang, Yingying
Lu, Ping
Liu, Mingzhu
Wang, Liwei
Sun, Yongwei
Yang, Minwei
Shen, Baiyong
Jin, Jiabin
Lu, Zipeng
Jiang, Kuirong
Shi, Yufeng
Xue, Jing
CANCER CELL, 2024, 42 (05) : 869 - 884.e9

← 1 2 3 4 5 →